These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32201508)

  • 21. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
    Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
    Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.
    Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ
    Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma.
    Chen S; Sun Z; Zhao W; Meng M; Guo W; Wu D; Shu Q; Chai J; Wang L
    Ann Transl Med; 2022 Feb; 10(3):138. PubMed ID: 35284540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
    Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer.
    Wu B; Wang J; Wang X; Zhu M; Chen F; Shen Y; Zhong Z
    Oncol Lett; 2020 Nov; 20(5):257. PubMed ID: 32994820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the association between C-X-C motif chemokine receptor subunits and tumor infiltration levels and prognosis in patients with early-stage pancreatic ductal adenocarcinoma.
    Wu QY; Yang CK; Rong LJ; Li JC; Lei LM
    Oncol Lett; 2020 Oct; 20(4):16. PubMed ID: 32774489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Lu J; Wu H; Wang L; Liang X; Liang Z; Liu T
    Diagn Pathol; 2017 May; 12(1):42. PubMed ID: 28558797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca
    Jiang SH; Zhu LL; Zhang M; Li RK; Yang Q; Yan JY; Zhang C; Yang JY; Dong FY; Dai M; Hu LP; Li J; Li Q; Wang YH; Yang XM; Zhang YL; Nie HZ; Zhu L; Zhang XL; Tian GA; Zhang XX; Cao XY; Tao LY; Huang S; Jiang YS; Hua R; Qian Luo K; Gu JR; Sun YW; Hou S; Zhang ZG
    Gut; 2019 Nov; 68(11):1994-2006. PubMed ID: 30826748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
    Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
    [No Abstract]   [Full Text] [Related]  

  • 36. FOLFIRINOX regulated tumor immune microenvironment to extend the survival of patients with resectable pancreatic ductal adenocarcinoma.
    Wu MY; Shen M; Xu MD; Yu ZY; Tao M
    Gland Surg; 2020 Dec; 9(6):2125-2135. PubMed ID: 33447563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
    Xu Y; Yao Y; Gao P; Cui Y
    Biochem Biophys Res Commun; 2019 Jan; 509(1):138-142. PubMed ID: 30591218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients.
    Hu H; Tu W; Chen Y; Zhu M; Jin H; Huang T; Zou Z; Xia Q
    J Cancer; 2020; 11(8):2022-2031. PubMed ID: 32127930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.